Fig. 2: Associations of HHLA2 expression in tumours with patient survival and tumour recurrence.

a Kaplan-Meier plot showing post-resection survival time of patients with pancreatic cancer or ampullary cancer with no, low or high HHLA2 expression in their tumours. b Kaplan-Meier plot showing recurrence-free survival after tumour resection of patients with pancreatic cancer or ampullary cancer with no, low or high HHLA2 expression in their tumours. c Kaplan–Meier plot showing post-resection survival time of pancreatic cancer patients with no, low or high HHLA2 expression in their tumours. d Kaplan–Meier plot showing post-resection survival time of ampullary cancer patients with no, low, or high HHLA2 expression in their tumours. e Kaplan–Meier plot showing recurrence-free survival after tumour resection of patients with pancreatic cancer with no, low or high HHLA2 expression in their tumours. f Kaplan–Meier plot showing recurrence-free survival after tumour resection of patients with ampullary cancer with no, low or high HHLA2 expression in their tumours.